155 related articles for article (PubMed ID: 10470141)
1. Alterations of tumour cells, stroma and apoptosis in rat prostatic adenocarcinoma following treatment with histamine, interleukin-2 and irradiation.
Johansson S; Landström M; Henriksson R
Anticancer Res; 1999; 19(3A):1961-9. PubMed ID: 10470141
[TBL] [Abstract][Full Text] [Related]
2. The response of Dunning R3327 prostatic adenocarcinoma to IL-2, histamine and radiation.
Johansson S; Landström M; Hellstrand K; Henriksson R
Br J Cancer; 1998 Apr; 77(8):1213-9. PubMed ID: 9579825
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-2 and histamine in combination inhibit tumour growth and angiogenesis in malignant glioma.
Johansson M; Henriksson R; Bergenheim AT; Koskinen LO
Br J Cancer; 2000 Sep; 83(6):826-32. PubMed ID: 10952789
[TBL] [Abstract][Full Text] [Related]
4. Improved efficacy of doxorubicin by simultaneous treatment with interferon-gamma and interleukin-2.
Lumsden AJ; Codde JP; Gray BN; van der Meide PH
In Vivo; 1992; 6(5):553-8. PubMed ID: 1457750
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical characterisation of immunological changes at the tumour site after chemo-immunotherapy with doxorubicin, interleukin-2 and interferon-gamma.
Lumsden AJ; Codde JP; Van der Meide PH; Gray BN
Anticancer Res; 1996; 16(3A):1145-54. PubMed ID: 8702226
[TBL] [Abstract][Full Text] [Related]
6. Tumour burden and interleukin-2 dose affect the interaction between low-dose total body irradiation and interleukin 2.
Safwat A; Aggerholm N; Roitt I; Overgaard J; Hokland M
Eur J Cancer; 2004 Jun; 40(9):1412-7. PubMed ID: 15177501
[TBL] [Abstract][Full Text] [Related]
7. Neutron or photon irradiation for prostate tumors: enhancement of cytokine therapy in a metastatic tumor model.
Hillman GG; Maughan RL; Grignon DJ; Yudelev M; Rubio J; Tekyi-Mensah S; Layer A; Che M; Forman JD
Clin Cancer Res; 2001 Jan; 7(1):136-44. PubMed ID: 11205901
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of colon tumor cells expressing FLT-3 ligand plus systemic IL-2 in mice with syngeneic colon cancer.
Sivanandham M; Stavropoulos CI; Kim EM; Mancke B; Wallack MK
Cancer Immunol Immunother; 2002 Apr; 51(2):63-71. PubMed ID: 11904730
[TBL] [Abstract][Full Text] [Related]
9. The mechanism of local tumor irradiation combined with interleukin 2 therapy in murine renal carcinoma: histological evaluation of pulmonary metastases.
Dezso B; Haas GP; Hamzavi F; Kim S; Montecillo EJ; Benson PD; Pontes JE; Maughan RL; Hillman GG
Clin Cancer Res; 1996 Sep; 2(9):1543-52. PubMed ID: 9816331
[TBL] [Abstract][Full Text] [Related]
10. NTP technical report on the toxicity studies of Dibutyl Phthalate (CAS No. 84-74-2) Administered in Feed to F344/N Rats and B6C3F1 Mice.
Marsman D
Toxic Rep Ser; 1995 Apr; 30():1-G5. PubMed ID: 12209194
[TBL] [Abstract][Full Text] [Related]
11. Toxicology and Carcinogenesis Studies of 5,5-Diphenylhydantoin (CAS No. 57-41-0) (Phenytoin) in F344/N Rats and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Nov; 404():1-303. PubMed ID: 12621514
[TBL] [Abstract][Full Text] [Related]
12. A stroma targeted therapy enhances castration effects in a transplantable rat prostate cancer model.
Johansson A; Jones J; Pietras K; Kilter S; Skytt A; Rudolfsson SH; Bergh A
Prostate; 2007 Nov; 67(15):1664-76. PubMed ID: 17854058
[TBL] [Abstract][Full Text] [Related]
13. [Role of radiotherapy in combined therapy of soft tissue sarcoma in children and adolescents].
Golubicić I; Nikitović M; Bokun J; Gavrilović D; Radosević-Jelić Lj
Srp Arh Celok Lek; 2000; 128(5-6):172-8. PubMed ID: 11089417
[TBL] [Abstract][Full Text] [Related]
14. NTP Toxicology and Carcinogenesis Studies of o-Benzyl-p-Chlorophenol (CAS No. 120-32-1) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1994 Jan; 424():1-304. PubMed ID: 12616287
[TBL] [Abstract][Full Text] [Related]
15. NTP Toxicology and Carcinogenesis Studies of AZT (CAS No. 30516-87-1) and AZT/alpha-Interferon A/D B6C3F1 Mice (Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1999 Feb; 469():1-361. PubMed ID: 12579204
[TBL] [Abstract][Full Text] [Related]
16. Addition of histamine to interleukin 2 treatment augments type 1 T-cell responses in patients with melanoma in vivo: immunologic results from a randomized clinical trial of interleukin 2 with or without histamine (MP 104).
Asemissen AM; Scheibenbogen C; Letsch A; Hellstrand K; Thorén F; Gehlsen K; Schmittel A; Thiel E; Keilholz U
Clin Cancer Res; 2005 Jan; 11(1):290-7. PubMed ID: 15671558
[TBL] [Abstract][Full Text] [Related]
17. [Effort to radically cure stage III and IV esophageal carcinoma with simultaneous radiotherapy and chemotherapy in standard clinical practice].
Farzad M; De Luca MC; Rubino G; Pirtoli L; Pepi F; Sebaste L; Ponticelli P; Atzeni G; Maranzano E; Silvano G
Radiol Med; 2001; 102(1-2):72-7. PubMed ID: 11677442
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of hepatocellular carcinoma by transfecting interleukin-12 and interleukin-2 fusion gene intrasplenically, an experimental study].
Yang JH; Fan RF; Qian QJ; You TG; Xue HB; Su CQ; Cao HF; Wu MC
Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):740-3. PubMed ID: 12899748
[TBL] [Abstract][Full Text] [Related]
19. [Potentiation of focal ultrasound treatment of prostate adenocarcinoma by concomitant chemotherapy with estramustine phosphate and paclitaxel].
Paparel P; Chapelon JY; Curiel L; Rabilloud M; Chesnais S; Gelet A
Prog Urol; 2004 Feb; 14(1):40-6. PubMed ID: 15098750
[TBL] [Abstract][Full Text] [Related]
20. Prostatic tumor regrowth after initially successful castration therapy may be related to a decreased apoptotic cell death rate.
Landström M; Damber JE; Bergh A
Cancer Res; 1994 Aug; 54(16):4281-4. PubMed ID: 7913874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
